Jonathan Ewbank has been Director General of ERINHA, the European Research Infrastructure on Highly Pathogenic Agents since late 2021. He has a PhD in biophysics, conducted at the MRC LMB in Cambridge and the EMBL in Heidelberg. After postdoctoral work at the Sloan-Kettering in New York, and McGill University, Montreal, he moved to the Centre d’Immunologie de Marseille Luminy (CIML), where for 25 years his group focused on the study of host-pathogen interactions.

For more information: https://erinha.eu/